Early follow-up of patients with acute heart failure by serial assessment of plasma NT-proBNP further discriminates outcome after hospital discharge

被引：0
作者：
Harjola, Veli-Pekka
Lassus, Johan
Siirila-Waris, Krista
Pulkki, Kari
Sund, Reijo
Melin, John
Peuhkurinen, Keijo
Nieminen, Markku S.
机构：
[1] Helsinki Univ Cent Hosp, Helsinki, Finland
[2] Univ Helsinki, Helsinki, Finland
[3] STAKES, Helsinki, Finland
[4] Cent Finland Cent Hosp, Jyvaskyla, Finland
[5] Kuopio Univ Hosp, SF-70210 Kuopio, Finland
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2007年 / 119卷
关键词：
D O I：
10.1016/j.ijcard.2007.03.021
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [31] Implementation of NT-ProBNP testing reduces hospital length of stay, morbidity and mortality in patients with acute decompensated heart failure
    Green, Sandy M.
    Redmond, Patrick
    Januzzi, James L.
    Aleryani, Samir
    Lee-Lewandrowski, Elizabeth
    Sluss, Patrick
    Lewandrowski, Kent B.
    [J]. CIRCULATION, 2006, 113 (21) : E806 - E807
  • [32] NT-proBNP is a sensitive marker for right ventricular dysfunction both in screening of patients with acute pulmonary embolism and in follow-up
    Lalho, M. K.
    Graner, M.
    Mustonen, P.
    Lassila, R.
    Harjola, V. -P.
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 : 85 - 85
  • [33] Relation between NT-proBNP plasma level changes and dosage of diuretic therapy in patients with acute or decompensated heart failure
    Gabrielli, F. A.
    Natali, R.
    De Marco, E.
    Savino, M.
    Lotrionte, M.
    Garramone, B.
    Comerci, G.
    Loperfido, F.
    [J]. EUROPEAN HEART JOURNAL, 2009, 30 : 874 - 874
  • [34] Electrocardiographic abnormalities and NT-proBNP levels at long-term follow-up of patients with dyspnea after pulmonary embolism
    Nilsson, Lars T.
    Andersson, Therese
    Carlberg, Bo
    Johansson, Lars A.
    Soderberg, Stefan
    [J]. SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2024, 58 (01)
  • [35] Usefulness of combined haemoglobin and NT-proBNP assessment at discharge in predicting 30-day and long term rehospitalization and death in patients with acute heart failure
    Navarin, SSilvia
    Stojcevski, B.
    Vetrone, F.
    Pencic, B.
    Cristofano, F.
    Sljivic, A.
    Majstorovic, A.
    Magrini, L.
    Celic, V.
    Di Somma, S.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 279 - 279
  • [36] Design and methodology of the NorthStar study: NT-proBNP stratified follow-up in outpatient heart failure clinics - A randomized Danish multicenter study
    Schou, Morten
    Gustafsson, Finn
    Videbaek, Lars
    Markenvard, John
    Ulriksen, Hans
    Ryde, Henrik
    Jensen, Jens C. H.
    Nielsen, Tonny
    Knudsen, Anne S.
    Tuxen, Christian D.
    Handherg, Jens
    Sorensen, Per J.
    Espersen, Geert
    Lind-Rasmussen, Soren
    Keher, Niels
    Egstrup, Kenneth
    Nielsen, Olav W.
    Abdulla, Jawdat
    Nyvad, Ole
    Toft, Jens
    Hildebrandt, Per R.
    [J]. AMERICAN HEART JOURNAL, 2008, 156 (04) : 649 - 655
  • [37] The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T
    Metra, Marco
    Nodari, Savina
    Parrinello, Giovanni
    Specchia, Claudia
    Brentana, Loretta
    Rocca, Patrizia
    FracasSi, Francesco
    Bordonall, Tania
    Milani, Patrizia
    DaneSi, Rossella
    Verzura, Giulia
    Chiari, Ermanna
    Cas, Livio Dei
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2007, 9 (08) : 776 - 786
  • [38] Influence of diabetes, heart failure, and NT-proBNP on cardiovascular outcomes in patients with atrial fibrillation-insights from a cohort study of 7850 patients with extended follow-up
    Hofer, F.
    Pailer, U.
    Sulzgruber, P.
    Gerges, C.
    Winter, M. P.
    Gottsauner-Wolf, M.
    Huelsmann, M.
    Kazem, N.
    Koller, L.
    Schoenbauer, R.
    Niessner, A.
    Hengstenberg, C.
    Zelniker, T. A.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 3) : S113 - S114
  • [39] In patients hospitalized for acute heart failure, is a strategy com- bining rapid and close follow-up visits with laboratories (including NT-proBNP) and rapid up-titration of treatments effective and safe?
    Lanthier, L.
    Plourde, M. -E.
    Cauchon, M.
    [J]. REVUE DE MEDECINE INTERNE, 2023, 44 (02): : 98 - 99
  • [40] Predictors of mortality and clinical usefulness of NT-proBNP, troponin T and C-reactive protein in follow-up after heart transplantation
    Milicic, D.
    Ljubas, J.
    Skoric, B.
    Gornik, I.
    Jelasic, D.
    Samardzic, J.
    [J]. EUROPEAN HEART JOURNAL, 2009, 30 : 389 - 389
12345